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Abstract
This study aimed to improve the hydrolase activity of the well-characterised bacterial sialidase from
Micromonospora viridifaciens. The enzyme and its mutated versions were produced in Bacillus
subtilis and secreted to the growth medium. Twenty amino acid positions in or near the active site
were subjected to site-saturation mutagenesis and evaluated on the artiﬁcial sialidase substrate
2-O-(p-nitrophenyl)-α-D-N-acetylneuraminic acid and on the natural substrate casein glycomacro-
peptide. A considerably higher fraction of the mutants exhibited increased activity on the artiﬁcial
substrate comparedwith the natural one, with themost proﬁcientmutant showing a 13-fold improve-
ment in kcat/Km. In contrast, no mutants displayed more than a 2-fold increase in activity on the nat-
ural substrate. To gain further insight into this important discrepancy, we analysed the stability of
mutants using the PoPMuSiC software, a property that also correlates with the potential for introdu-
cing chemical variation, after validating themethodwith a set of experimental stability estimates.We
found a signiﬁcant correlation between improved hydrolase activity on the artiﬁcial substrate and
reduced apparent stability. Together with the minor improvement on the natural substrate this
shows an important difference between naturally evolved functionality and new laboratory function-
ality. Our results suggest that when engineering sialidases and potentially other proteins towards
non-natural substrates that are not optimized by natural evolution, major changes in chemical prop-
erties are advantageous, and these changes tend to correlate with decreased stability, partly explain-
ing commonly observed trade-offs between stability and proﬁciency.
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Introduction
In protein evolution an important characteristic of enzymes (and other
proteins) is their ability to evolve to adapt to new functions (Tokuriki
and Tawﬁk, 2009). This encompasses both altered substrate speciﬁcity
(but same reaction type) and catalysis of new reactions. In fact, it is
clear that many proteins beside their main activity can also catalyse
other reactions, normally with lower efﬁciency. These enzymes appear
to have arisen from ‘generalist’ ancestors (enzymes with broad
speciﬁcity) after adaptation towards high speciﬁcity and activity for
a given reaction (Khersonsky and Tawﬁk, 2010).
A prerequisite for obtaining and maintaining functionality is that
speciﬁc amino acids are present at important positions in the structure.
These functionally important residues have been shown to generally
reduce protein stability (Tokuriki et al., 2008). Enzyme stability is nor-
mally not maintained at a level substantially higher (typically 5–15
kcal/mol) than that required to function in its natural setting (Branden
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and Tooze, 1999). Trade-offs between stability and activity are a
major issue in protein engineering, and several causes for these trade-
offs have been suggested (Tokuriki et al., 2008; Kepp and Dasmeh,
2014). As adaptation towards new functionality often proceeds via
destabilizing mutations, an evolutionary trajectory appears to proceed
via initial accumulation of stabilizing mutations to allow incorpor-
ation of functional, but often destabilizing mutations (Tokuriki
et al., 2008). This trade-off between stability and activity has been ob-
served in both laboratory and natural evolution (Nagatani et al., 2007;
Tokuriki et al., 2012; Studer et al., 2014).
Laboratory evolution of enzymes has demonstrated that in many
cases latent promiscuous activities can be improved with a minimal
amount of mutations, often with a relatively low effect on the main
activity (Khersonsky et al., 2006). When approaching the optimum,
a diminishing return is seen, that is, additional mutations will lead
to relatively smaller improvement in proﬁciency (Tokuriki et al.,
2012). This would indicate that improvement of an enzyme with
respect to its natural function (for which it has been specialized)
would be more difﬁcult and less substantial than improving side activ-
ities. However, it should be noted that many natural enzymes appear
to be far from their proﬁciency optimum because of additional con-
straints on the proteins (Tokuriki et al., 2012).
In the laboratory evolution of enzymes, the construction of smaller
libraries is beneﬁcial as this will reduce the amount of screening
needed. To do so, semi-rational mutant designs in which select resi-
dues are subjected to site-saturation mutagenesis can be useful. As
the observations on stability–function trade-off indicate that most
functional mutations are destabilizing, this might be a useful param-
eter for selection of residues for mutagenesis, given that the target
enzyme is stable enough to accommodate them.
In this study, a sialidase (EC 3.2.1.18) fromMicromonospora vir-
idifaciens was used as a model enzyme. Sialidases are enzymes that
hydrolyze sialic acids or sialyl groups of glycans and are found in all
domains of life. Bacterial sialidases are classiﬁed in glycosyl hydrolase
family 33 and their structures are of the six-bladed β-propeller type
(Crennell et al., 1993). As retaining glycosidases, they employ a
double-displacement mechanism and use a Tyr residue as catalytic
nucleophile (Watts et al., 2003) while a conserved Asp-Glu pair is
involved in general acid/base catalysis (Chan et al., 2012). Interesting-
ly, this enzyme can retain function uponmutation of either of the cata-
lytic residues (D92, E260 and Y370) (Watson et al., 2003; Chan et al.,
2012). A conserved arginine triad (R68, R276 and R342) stabilizes
the carboxyl group of sialic acid (Crennell et al., 1993). The M. viri-
difaciens sialidase is the best characterized bacterial sialidase. It has a
broad substrate speciﬁcity hydrolysing both α-2,3-, α-2,6- and
α-2,8-glycosidic linkages and exhibits maximum activity at pH 5
(Aisaka et al., 1991). The kcat/Km of the enzyme is 8.5 × 10
6 M−1 s−1
for hydrolysis of the artiﬁcial substrate 2-O-(p-nitrophenyl)-
α-D-N-acetylneuraminic acid (pNP-Neu5Ac) and 0.36 × 106 M−1 s−1
for hydrolysis of the natural substrate 3′-sialyllactose (Watson et al.,
2003).
Sialidases have gained signiﬁcant interest in relation to synthesis of
sialoglycans, due to their trans-sialidase activity (Schmidt et al., 2000;
Jers et al., 2014). Several studies have demonstrated potential uses of
sialidases as therapeutics targeting sialoglycans, most notably in the
case of nervous system injuries. Upon injury, inhibitors of axon regen-
eration, some of which bind to sialylated receptors, accumulate to halt
axon outgrowth. In rats, the administration of sialidase improved
spinal axon outgrowth and recovery after spinal cord contusive
injury (Yang et al., 2006; Mountney et al., 2010). While several
protein-engineering efforts have been directed towards improving
trans-sialidase activity (Paris et al., 2005; Jers et al., 2014;
Pierdominici-Sottile et al., 2014), to our knowledge no attempts
have been made to improve hydrolase activity of sialidases despite
their importance in disease and inﬂammation. With potential applica-
tions in clinical settings emerging, we set out to probe the potential for
improving the hydrolase activity of the well-characterized sialidase
from M. viridifaciens by mutagenesis.
In this study, we subjected selected active site-amino acids to
site-saturation mutagenesis and tested the mutant libraries on both a
natural substrate, casein glycomacropeptide (cGMP), containing sialic
acid α-2,3-linked to galactose and α-2,6-linked to N-acetylgalactosamine
(Saito and Itoh, 1992), but also on the widely used non-natural test sub-
strate pNP-Neu5Ac. This substrate differs from its natural counterparts
by having Neu5Ac linked to a para-nitrophenyl group opposed to most
commonly galactose in natural glycans. When using pNP-Neu5Ac, a
high proportion of mutants displayed activities substantially higher
than the wild type and overall up to 25-fold higher activity. In contrast,
screening on the natural substrate cGMP led to much less frequent and
limited improvements.
The improved activities on pNP-Neu5Ac correlated with increased
chemical variation and computed stability changes, conﬁrming the hy-
pothesis that the natural substrates resemble an evolved proﬁciency
optimum, whereas activity on the non-natural substrate is associated
with major adaptation upon variation in chemical properties. Thus,
we conclude that for optimizing a protein towards non-natural sub-
strates not optimized by natural evolution, major changes in chemical
properties that tend to correlate with decreased stability are more likely
to successfully improve functionality, consistent with a trade-off
between stability and proﬁciency as widely debated in protein engin-
eering (Tokuriki et al., 2008; Dellus-Gur et al., 2013).
Materials and methods
Substrates
pNP-Neu5Ac and colominic acid were purchased from Sigma-Aldrich
(Steinheim, Germany). 3′-Sialyllactose and 6′-sialyllactose were ob-
tained from Carbosynth (Compton, UK). The commercial cGMP
product LACPRODAN CGMP-20 with a sialic acid content of
∼9% (w/w) was supplied by Arla Foods (Viby, Denmark).
Mutant selection and bioinformatics analysis
Pymol v1.3 (Schrödinger) was used to identify amino acids within
10 Å of the sialic acid binding site, based on the crystal structure
with PDB code 1EUS (Gaskell et al., 1995). Individual sites were
selected based onmanual inspection of the structure. Since the number
of mutations prevented experimental stability assessment, we analysed
the stabilities of the mutants using the PoPMuSiC software (Dehouck
et al., 2011) with the structure templates PDB 1EUS, 1EUT, 1EUU and
1EUR. This method has been shown previously to have a correlation
coefﬁcient between predicted stability changes and experimental mea-
surements of ∼0.7 and to give good accuracy especially for batches of
mutants (Worth et al., 2011; Kepp, 2014). PoPMuSiC computes the
ΔΔG (change in the free energy of protein folding) for a mutant
based on parameterized, environment-dependent empirical substitu-
tion frequencies in orthologues, i.e. it measures the propensity of a
given substitution based on empirical substitution patterns. Rare
substitutions are thus associated with large variations in chemical
properties that are likely to change the protein function more, and
these correspondingly tend to exhibit larger ΔΔG, i.e. tend to be
more destabilizing.
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Bacterial strains and growth conditions
Escherichia coli NM522 was used for plasmid propagation. Escheri-
chia coli was grown in LB medium (10 g/l tryptone, 5 g/l yeast extract
and 10 g/l NaCl) shaking at 37°C. Bacillus subtilis strains SCK6
(Zhang and Zhang, 2011) and WB800 (Wu et al., 2002) were used
for protein synthesis. Bacillus subtilis was grown shaking at 37°C in
LB medium and C-medium (Martin-Verstraete et al., 1990) supple-
mented with 5 g/l glucose and 2% LB medium (CG-LB medium).
The growth media were supplemented with kanamycin at 25 µg/ml
for E. coli and 50 µg/ml for B. subtilis.
DNA manipulation and strain construction
The protein sequence of M. viridifaciens sialidase (Uniprot ID
Q02834) contains a signal sequence constituted by amino acids
1–37 (Sakurada et al., 1992). A synthetic gene encoding the mature
protein (38–647) initiated by methionine and with a C-terminal
6xHis-tag was codon optimized for expression in B. subtilis and
synthesized by DNA2.0 (Menlo Park, CA, USA). The gene fragment
was inserted in the vector pDP66K-PME (Øbro et al., 2009) between
the NcoI and HindIII restriction sites replacing the PME-encoding
gene and placing the sialidase gene in frame with the CGTase signal
peptide and under control of the P32 promoter (Penninga et al.,
1996). The use of the NcoI restriction site led to the mutation of I38
to glycine. Amino acid numbering will follow that of the wild-type
protein. Site-saturated mutagenesis of 20 positions was done by
GeneArt (Regensburg, Germany). Two point mutations, I91E and
S201L, were introduced in the wild-type gene by overlapping primer
mutagenesis using the oligonucleotides displayed in Table I. The PCR
products were restricted with NcoI and HindIII and inserted in
pDP66K-PME. The 20 libraries of plasmids and the two constructed
single mutant-encoding plasmids were used to transform B. subtilis
SCK6 (Zhang and Zhang, 2011). This strain contains the comK
gene under control of a xylose-inducible promoter and was trans-
formed with plasmid DNA as described previously (Silva et al.,
2013). Bacillus subtilis WB800 was transformed with pDP66K con-
taining the gene encoding the wild-type sialidase using a one-step
transformation protocol (Jarmer et al., 2002).
Screening of site-saturation libraries
For each of the site-saturation libraries, screening was done in 96-well
microtitre plate format with 90 transformants (4.5-fold coverage) and
six wild-type enzymes per plate.Bacillus subtiliswas transformedwith
the site-saturation library and wild-type plasmid, and after overnight
incubation at 37°C, the transformants were transferred to 125 µl LB
medium with kanamycin in a 250-µl round bottom microtiter plate
(Nunc), covered with Airpore sheet (Qiagen) and incubated at 37°C
with shaking at 250 rpm for 6 h. The preculture step reduced
well-to-well variation from growth. From this preculture, 5 µl was
used to inoculate 500 µl CG-LB medium with kanamycin in a 2-ml
deepwell plate (Eppendorf ). The plate was covered with airpore
sheet and incubated at 37°C with shaking at 250 rpm for 16 h.
At this point, the supernatants containing the secreted enzymes were
harvested by centrifugation for 15 min at 5000 and 4°C and kept on
ice or stored at −20°C in 10% glycerol until used in the assays.
Protein production
For larger scale production of selected enzyme variants, 50 ml cultures
were grown by inoculating 50 ml LB medium with kanamycin to
OD600 of 0.05 and incubation with shaking at 37°C for 23 h. At
this point, the supernatant was harvested by centrifugation for
15 min at 5000 g and 4°C and passed through ﬁrst a 0.50 and then
a 0.20 µm ﬁlter. The ∼48 ml supernatant was then concentrated to
less than 1 ml using a Vivaspin20 10 MWCO concentrator (Sartorius
AG), mixed with 10 ml puriﬁcation buffer (20 mM sodium phos-
phate, 500 mM NaCl, pH 7.4) with 10 mM imidazole and concen-
trated to 1.5 ml. The concentrated sample was applied to a His spin
trap column (GE Healthcare) and washed once with 600 µl of the
same buffer, then four times with 600 µl puriﬁcation buffer containing
30 mM imidazole and ﬁnally eluted in 400 µl puriﬁcation buffer with
300 mM imidazole. To reduce imidazole concentration to less than
0.5 mM, several rounds of concentration and dilution in storage
buffer (20 mM sodium phosphate, 100 mM NaCl and 10% glycerol,
pH 7.4) were done using Vivaspin6 10 MWCO concentrator (Sartor-
ius AG). Final volume was adjusted to 500 μl. Protein concentration
was estimated using the BCA assay (Thermo Scientiﬁc) with BSA as
standard.
Sialidase activity assays
Two different enzyme assays were used for testing sialidase activity:
one using the substrate pNP-Neu5Ac and another for testing activity
on various natural substrates. The pNP-Neu5Ac hydrolase assay was
done in a 50 mM phosphate-citrate buffer at pH 7 with 0.75 mM
pNP-Neu5Ac at 30°C using various amounts of enzyme. In the screen,
5 μl of the culture supernatant was used in a 100-μl reaction. Reactions
were started by addition of the substrate and monitored continuously
in a spectrophotometer at 410 nm absorbance. Reactions were fol-
lowed for 1 h, and the initial reaction rates were calculated as the
slope of the linear portion of the curves and presented in the following
as a percentage of the wild-type enzyme activity. For testing the puri-
ﬁed enzymes, 1.5 µg/ml His-tagged wild-type enzyme was used, while
for the mutant enzymes, a 5–14 times lower concentration was used.
To assess thermostability, 60 μg/ml enzymewas incubated at 60°C for
0, 7.5, 15 and 30 min and residual activity was measured as described
above. To estimate kcat and Km, substrate velocity curves were gener-
ated with puriﬁed enzyme in a discontinuous assay. Samples were ter-
minated by addition of Na2CO3 to a ﬁnal concentration of 0.25 M.
The values of kcat and Km were estimated by non-linear regression
using the software Prism 6 (GraphPad software, inc.).
For measurement of hydrolysis of natural substrates, reactions
were performed with either 1 mM 3′-SL, 1 mM 6′-SL or 1 mM
cGMP-bound sialic acid in 50 mM phosphate-citrate buffer (pH 5
or 7) using 10 μl of 25-fold diluted culture supernatant in 50 μl reac-
tions or 5 μg/ml puriﬁed enzyme. Reactions were started by addition
of enzyme and stopped by adding H2SO4 to a ﬁnal concentration of
45 mM. Quantiﬁcation of free sialic acid was done using a modiﬁed
thiobarbituric acid assay (Jers et al., 2014).
Results
Cloning, expression and puriﬁcation of M. viridifaciens
sialidase in B. subtilis
The sialidase fromM. viridifacienswas previously produced in bacter-
ial hosts Streptomyces lividans and E. coli (Sakurada et al., 1992;
Watson et al., 2003). To allow efﬁcient secretion to the culture me-
dium, we attempted to use B. subtilis as a production host since this
would simplify screening in microtiter plate format. Expression of a
codon-optimised gene in B. subtilis SCK6 (a strain devoid in two of
the major secreted proteases) allowed production and secretion of
the 6xHis-tagged sialidase (Fig. 1). Besides the full length protein, a
smaller form of ∼28 kDa was observed similar to the size of the
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C-terminal, non-catalytic form reported previously (Sakurada et al.,
1992). It was attempted to produce the enzyme in B. subtilis
WB800, a strain devoid of eight proteases, but this did not reduce deg-
radation (Fig. 1) and hence the strain B. subtilis SCK6was used for the
reported work.
Mutations of active site amino acids
In order to investigate the possibility of improving the catalytic proﬁ-
ciency of sialidases, we mutated a number of positions in or near the
active site. To maximize the possibility of identifying relevant muta-
tions, we performed single-amino acid site-saturation mutagenesis in
each of 20 selected positions. Positions were selected based on inspec-
tion of the solved structure (Gaskell et al., 1995; 1EUS). These
included nine sites comprising part of the sialic acid binding pocket:
I69, A93, S130, D131, P132, V148, F155, L170, F203 and D259.
Of these, D131 and D259 form hydrogen bonds with the inhibitor
DANA in the crystal structure and P132 is buried underneath the
pocket. Three amino acids N310, N311, and S369 are located close
to the catalytic tyrosine, and we envisioned that they might modulate
the covalent intermediate or transition state and thus affect turnover.
A number of surface-exposed amino acids were selected because they
might change the interaction with the substrate molecules to which
sialic acid is bound. These included G90, I91, G154, Q153, A156,
and F234. Finally, N66 a second-sphere, surface-exposed residue in
close vicinity to conserved R68 was selected. None of the active site
amino acids strictly conserved in all sialidases (R68, D92, E260,
R276, R342, and Y370) were targeted. The sites selected for mutagen-
esis are shown in Fig. 2.
Screening of site saturation libraries reveals variable
activities on pNP-Neu5Ac and cGMP
Themutant libraries were synthesized to contain genes encoding all 20
amino acids in a given position. The DNA was used to transform
B. subtilis and transformants were picked to a 96-well microtiter
plate. Since the secreted sialidase only constituted a small fraction of
total secreted protein (Fig. 1), it was not possible to normalize activity
with respect to the amount of the sialidase. To compare the mutants, it
was therefore important to assure similar growth in all wells. In initial
experiments, a relatively high well-to-well variation was observed due
to differences in inoculum used. That was alleviated by synchronizing
growth by pre-culturing the cells to early stationary phase, and using
this culture for inoculating the enzyme production plate. Cells
were removed by centrifugation and supernatant containing the se-
creted enzyme was assayed for enzyme activity on the substrates
pNP-Neu5Ac and cGMP. To validate the method, this pipeline was
tested using DNA encoding the wild-type enzyme. This was repeated
three times, and the activities of individual wells were between
80–125% of the average activity when tested on pNP-Neu5Ac.
Next, the libraries were tested on the substrates pNP-Neu5Ac and
cGMP. For each amino acid 90 transformants were tested and activ-
ities (initial reaction rates) were normalized with respect to the activity
of the six replicates of the wild-type enzyme. Since the same enzyme
preparation was used, any systematic error related to enzyme concen-
tration would cancel out in the comparison of relative activities on the
two substrates. The pooled results for all transformants tested are pre-
sented in a histogram (Fig. 3). Results for individual positions are pre-
sented in Supplementary Fig. S1. When screened on cGMP, a larger
number of mutants showed no or low activity than on pNP-Neu5Ac.
Further, the majority of active mutants exhibited wild-type-level activ-
ity on cGMP and very few mutants had an increased activity on this
substrate. No mutants had an activity >160%. When tested on the
artiﬁcial substrate pNP-Neu5Ac, the majority of mutants also exhib-
ited wild-type-level activity but the number of mutants exhibiting
increased activity was considerably higher, and the most active
mutants displayed more than 10-fold increase in activity under the
conditions used.
Considering the individual positions mutated, it was apparent that
irrespective of the substrate, changing the amino acid D131 was
Table I. List of oligos. Mutated codons are shown in bold. MCS is the multiple cloning site
Name Sequence Description
pDP66K fwd CGAATTCGGTCCTCGGGATATGATAAG Anneals upstream MCS
pDP66K rev GCCTTCTGCGTCCGGTCGATCAGGGAGGATATCG Anneals downstream MCS
Mv I91E Fwd CCCAACAGGAGAAGATGCACCTGGACCGAACTC I91E
Mv I91E Rev CAGGTGCATCTTCTCCTGTTGGGCGGCCGTC I91E
Mv S201L Fwd TGGATGGCGCTTGAGATTTGCTGCTAGCGGTGAAGG S203L
Mv S201L Rev CAGCAAATCTCAAGCGCCATCCAGGATCCGG S203L
Fig. 1. SDS-polyacrylamide gel of M. viridifaciens sialidase produced in
B. subtilis. M is a molecular weight marker, Lanes 1 and 2 shows
supernatant and puriﬁed sialidase produced in B. subtilis strains SCK6 and
lanes 3 and 4 shows supernatant and puriﬁed sialidase produced in
B. subtilis WB800.
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accompanied by loss of activity in the majority of substitutions.
The amino acids D259, on the other hand, appeared to be essential
for hydrolysis of cGMP but not pNP-Neu5Ac. Mutation of the two
positions I69 and F203 also led to signiﬁcant decrease in the hydroly-
sis of cGMP, whereas on pNP-Neu5Ac, most mutations of F203
strongly improved activity. The largest fraction of mutants improved
towards pNP-Neu5Ac (79 of 90 mutants) was observed for F155,
whereas most mutations in this position led to a reduction in activity
on cGMP.
Mutations improving the hydrolysis activity
on pNP-Neu5Ac
To provide a foundation for interpreting the reasons underlying the dif-
ference in improvements observed, we sequenced the variants that
showed the largest increase in activity towards pNP-Neu5Ac (Supple-
mentary Table SI). Further, we wanted to verify the screening results
on a set of the variants exhibiting the largest increase in activity on
pNP-Neu5Ac. To this end, plasmids were puriﬁed and entire genes
were sequenced, and the corresponding strains were grown in larger
Fig. 2. Amino acid positions in the active site selected for mutagenesis. Selected amino acids are shown in green, catalytic residues D92, E260, and Y370 are in grey
while the structure-bound ligand is in blue.
Fig. 3. Screening ofmutant libraries. Histogram presenting the activity (% compared with wild type) of 1800mutants tested on (A) pNP-Neu5Ac and (B) cGMPwith a
bin size of 20%. 475 and 859 mutants showed no or low activity (0–20% wild-type activity) on pNP-Neu5Ac and cGMP respectively and are not shown in the
histograms.
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scale to allow production and puriﬁcation of the 6xHis-tagged en-
zymes.We found that themost proﬁcient mutant in the screen possessed
both mutation I91E but also S201L. The corresponding enzymes were
produced and tested on pNP-Neu5Ac (Supplementary Figs S2 and 4).
This largely conﬁrmed the screening results except it appeared that the
relative activities of most improved variants were underestimated in the
screen, and mutants with more than 20-fold improvement in activity
was observed (Fig. 4). The mutant I91E/S201L exhibited the highest ac-
tivity with a 27-fold improvement. When testing the individual single
mutants, I91E had wild-type like activity whereas S201L could explain
most of the improvement (Supplementary Fig. S3).
As indicated in the screen, neither of the mutants showed signiﬁ-
cant improvement on the natural substrate cGMP. To conﬁrm the gen-
erality of this observation, we tested the puriﬁed enzymes on three
other natural substrates 3′- and 6′-sialyllactose (Neu5Ac α-2,3- and
α-2,6-linked to galactose respectively), and colominic acid (Neu5Ac
polymer linked by α-2,8 bonds) (Supplementary Fig. S4). The results
conﬁrmed the overall observation, with some variants showing slight
improvements and others showing signiﬁcantly reduced activity on
these substrates. To allow detection of the chromophore pNP in a con-
tinuous assay, the screening using pNP-Neu5Ac was done at pH 7,
while the cGMP screen was done at pH 5, the optimum pH for the
wild-type enzyme (Aisaka et al., 1991). To assess whether this discrep-
ancy could account for the differences observed between the two sub-
strates, we analysed the puriﬁed mutant enzymes on 3′-sialyllactose at
pH 5 and 7 (Supplementary Fig. S4). This conﬁrmed that the observed
improvements were not due to a change in pH optimum or range.
Structure analysis and hypothesis for effect of mutations
After having showed that the mutagenesis strategy preferentially
yielded mutants with improved activity on pNP-Neu5Ac, we investi-
gated whether the number of improving mutations would correlate
with the chemical variation and stability effects in the library. The
wild-type enzyme showed no signiﬁcant loss of activity after 30 min
at 50°C (Supplementary Fig. S5). With the enzyme assays being per-
formed at 30°C, only strongly destabilized/non-folding mutants
would be affected at these conditions, and since the typical effect on
stability of a mutation is ∼1 kcal/mol (Tokuriki et al., 2008), stability
was not likely to affect yield and protein concentration. To assess
chemical variation and stability effects, we used PoPMuSiC where
the computed stability change ΔΔG for each mutation provides a
measure of the environment-dependent substitution propensity
based on empirical substitution frequencies of orthologues, and
these can then be summed for each of the 20 sites. A large positive
value of ΔΔG thus implies both a highly destabilizing mutant and a
natural-evolution-wise unlikely substitution. To validate the applica-
tion of PoPMuSiC, we experimentally determined the half-lives of
17 mutants and observed decreased half-lives for the 17 mutants pre-
dicted to have destabilizing mutations (Supplementary Fig. S6).
We then assessed whether there were correlations between these
ΔΔG values for all 20 individual sites and the number of mutants
with higher, similar or lower activity compared with the wild-type en-
zyme. This approach gives a site-speciﬁc estimate of the evolvability
and a high value for a site implies that most mutations in the site are
unlikely to occur in natural evolution and are associated with loss of
stability due to major changes in the chemical properties of the
protein. We found no correlations between activity on cGMP and
the PoPMuSiC results, indicating that the protein is nearly optimal
(by evolution) for activity on natural substrates, and any changes in
the sites are likely to have small or negative effect on activity irrespect-
ive of chemical properties and stability (Supplementary Fig. S7).
In contrast, there was a markedly different and statistically signiﬁ-
cant correlation between the average PoPMuSiC ΔΔG of a site and the
site-speciﬁc activities of the most active mutants on the non-natural
substrate pNP-Neu5Ac. This indicates much more room for improve-
ment, and importantly, improved activity is associated with sites that
exhibit major chemical changes and decreased stability (Fig. 5).
We ﬁnally considered the amino acid positions that yielded the lar-
gest increases in activity on pNP-Neu5Ac. For the most improved var-
iants, the mutations in V148, F155, L170, and F203 were all located
in the sialic acid-binding pocket within 4–5 Å of theN-acetyl group of
sialic acid (Fig. 6). The mutation S201L that was functionally import-
ant in the most improved variant was located in the second sphere in
close vicinity to these four sites.We further determined the kcat andKm
of the wild-type sialidase and the most improved mutants I91E/S201L
and F155T. Both mutant enzymes had a slightly increasedKmwhereas
the improvement observed in the screen was due to an increase in kcat
(Table II and Fig. S8). Sequencing of mutants of the two aspartic acid
residues involved in sialic acid binding indicated that D131 only
remained active when mutated to glutamic acid. However, this re-
duced the activity on pNP-Neu5Ac, and no activity was observed on
cGMP, indicating its functional importance. For D259, mutation to
glutamic acid increased activity towards pNP-Neu5Ac while other
mutations led to reduced activity and in this case, we found no mu-
tants active on cGMP.
Fig. 4. Activity of the most proﬁcient mutants selected on pNP-Neu5Ac. Activity increments compared with activity of the wild-type sialidase. Negative control (NC)
was a reaction without enzyme added. Average of four replicates.
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Discussion
In this work, we aimed to assess the potential for improvement of a
well-characterized sialidase towards both artiﬁcial and natural sub-
strates. To this end, we designed, cloned, expressed, and characterized
mutants resulting from saturated mutagenesis at 20 positions near the
active site. Positions were selected based on inspection of the solved
structure with PDB code 1EUS (Gaskell et al., 1995). None of the
strict catalytic residues (R68, D92, E260, R276, R342 and Y370)
were selected, but except from that, conservation within the sialidase
family was not considered since we wanted to optimize in vitro
proﬁciency, and these conserved sites are likely to add additional
constraints on the protein relating to, e.g. in vivo regulation and
modiﬁcation.
The potential for improving the catalytic efﬁciency of an enzyme
largely depends on how well it is optimized for its particular function.
In a previous study, the catalytic efﬁciency kcat/Km was determined for
the substrate pNP-Neu5Ac and a natural substrate 3′-sialyllactose in-
dicating a 10-fold higher efﬁciency of the enzyme towards the
pNP-substrate (Watson et al., 2003). For other classes of enzymes,
large rate accelerations have been observed when using artiﬁcial
pNP-substrates (Indurugalla et al., 2006), reﬂecting elevated intrinsic
reactivity of the substrate rather than the enzyme being optimized for
this particular substrate. Consequently, wewanted to investigate if and
how the potential for optimizing the enzyme towards non-natural sub-
strates is higher than for natural substrates.
To test this, we assayed the mutant libraries on two substrates, the
artiﬁcial test substrate pNP-Neu5Ac and the natural substrate cGMP
derived from casein. This demonstrated a much higher proportion of
beneﬁcial mutations with respect to hydrolysis of the artiﬁcial sub-
strate compared with the natural one and the best mutant (I91E/
S201L) had a 27-fold improvement in activity whereas for cGMP
only slight improvement was observed. This reﬂects substrate-
speciﬁc differences and consequently mutations selected speciﬁcally
to favour action on the artiﬁcial substrate. This is in line with obser-
vations on promiscuous enzymes, where it is well established that
while changing main function can be difﬁcult, a weaker side activity
often can be substantially improved with one or few mutations often
without signiﬁcantly affecting the main activity (Khersonsky et al.,
2006).
Both in laboratory and natural evolution there is a trade-off be-
tween stability and function (Nagatani et al., 2007; Tokuriki et al.,
2012; Studer et al., 2014). Since we in this study analysed single
mutants only, such effects would not be readily apparent. Destabiliz-
ing mutations would be expected to be tolerated by our model en-
zyme, since it appears reasonably stable (temperature optimum at
52°C) (Watson et al., 2003). When analysing the stability change
of mutations, there was a signiﬁcant correlation between the average
PoPMuSiC ΔΔG and activity on the artiﬁcial substrate for the most
improved mutants while no correlation with activity on the natural
substrate was observed. This would be consistent with the view
that the protein is nearly optimal (by evolution) for activity on nat-
ural substrates: Any changes are then likely to have small or negative
effect on activity regardless of chemical properties and stability, i.e.
we have probed a proﬁciency optimum (in evolutionary terms, resem-
bling a partial ﬁtness optimum, if other selection pressures on the
protein are ignored).
In contrast, when optimizing a protein for a new, non-natural sub-
strate, there is much more room for improvement since the substrate is
no longer optimal, and importantly, improved activity is associated
with sites that exhibit major chemical changes and thus, decreased sta-
bility. The observation that the activity towards non-native substrates
can be readily improved and that the improvement correlates with the
potential for introducing chemical variation in a given amino acid pos-
ition has direct implications in protein engineering. On the other hand,
none of the single mutants were markedly improved towards the
Fig. 6. Representation of the positions with most improved variants. The
mutated positions V148, F155, L170 and F203 are shown in green, the site
S201 that yielded the most improving mutation is shown in yellow while the
catalytic residues D92, E260 and Y370 are shown in grey. The ligand is
shown in blue.
Table II. Kinetic constants for wild-type and most proﬁcient mutants
at pH 7 with pNP-Neu5Ac as substrate
kcat [s
−1] Km [mM] kcat/Km [mM
−1 s−1]
Wild type 0.30 ± 0.01 0.25 ± 0.03 1.2
I91E/S201L 5.4 ± 0.1 0.44 ± 0.04 12.3
F155T 4.2 ± 0.1 0.31 ± 0.02 13.6
Fig. 5. Correlation between potential for chemical variation and improvement
towards hydrolysis of pNP-Neu5Ac. PoPMuSiC predictions were used as a
measure of potential chemical variation and were for each amino acid
position plotted against the number of mutants that exhibited improved
activity towards pNP-Neu5Ac.
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natural substrate. In nature, the enzyme is likely to have been selected
for efﬁcient hydrolysis of galactose-linked sialic acid and could poten-
tially, in sequence space, have reached a local optimum. In that case, it
might require multi-mutants to enable signiﬁcant improvements in
activity which would not be captured by our strategy (Tracewell and
Arnold, 2009).
When analysing the effect in individual positions, the functional
importance of especially D141 and D259 that interact directly with
sialic acid, was apparent with most mutants showing no activity.
For the reaction on pNP-Neu5Ac, mutation to the chemically similar
but larger amino acid glutamic acid was tolerated (2-fold reduction
and 2.5-fold increase in activity respectively). On cGMP, bothmutants
had no detectable activity indicating a difference in the position of si-
alic acid in the binding pocket. Further, it appeared that the largest im-
provements were observedwith amino acids (V148, F155, L170, F203
and S201L) located in the sialic acid-binding pocket in close vicinity to
the N-acetyl group of sialic acid. This might indicate that positioning
of sialic acid in the binding pocket was changed likely due to second-
ary effects of the nitrophenyl group. This would imply that the major
functional role of the mutations would be to allow an alternative po-
sitioning of sialic acid that would lead to a more optimal positioning
of the nitrophenyl group. For the two most improved mutants, hardly
any effect was observed on Km, while kcat was 12–13 times higher
(Table II and Supplementary Fig. S8). This increased turnover, how-
ever, was substrate-dependent therefore not translating into increased
overall catalytic activity of the enzyme as was observed for the cGMP
data set.
pNP-Neu5Ac is one of the most frequently used test substrates for
sialidases. While the use of artiﬁcial test substrates allows easy and fast
screening, it is not necessarily indicative of the activity towards the nat-
ural substrate (Lee, 2010). This is also apparent in this data set, namely
that there was not a clear correlation between activity of mutants on
the artiﬁcial and natural substrate. The use of pNP-Neu5Ac as an
indicator of potential sialidase activity may be reasonable, but with
respect to characterization of biological functions of sialidases, more
relevant, natural substrate should be chosen.
In conclusion, using a well-studied sialidase as an example, we
used site-saturation mutagenesis of 20 sites close to the active site
and subsequent activity characterization of mutants to investigate
the ability of the enzyme to improve activity towards both non-natural
and natural substrates. We show that while there is little room for
improvement towards a natural substrate, consistent with the protein
being near the proﬁciency optimum, there is substantial room for
producing highly proﬁcient sialidases with activity towards pNP-
Neu5Ac. Furthermore, this tendency of improvement correlated
with chemical variation introduced in the mutated sites, which again
correlates with stability decrease, as computed by the PoPMuSiC
algorithm and validated experimentally for selected mutants and the
wild type. This study thus provides a mechanistic explanation for sta-
bility–activity trade-offs found in protein engineering when the inves-
tigated activities are not towards the natural substrate, which is
commonly the case.
Supplementary data
Supplementary data are available at PEDS online.
Funding
This work was supported by the Danish Strategic Research Council
(09-067134).
References
Aisaka,K., Igarashi,A. and Uwajima,T. (1991) Agric. Biol. Chem., 55, 997–1004.
Branden,C. and Tooze,J. (1999) Introduction to Protein Structure. Garland,
New York.
Chan,J., Watson,J.N., Lu,A., Cerda,V.C., Borgford,T.J. and Bennet,A.J. (2012)
Biochemistry, 51, 433–441.
Crennell,S.J., Garman,E.F., Laver,W.G., Vimr,E.R. and Taylor,G.L. (1993)
Proc. Natl. Acad. Sci. USA, 90, 9852–9856.
Dehouck,Y., Kwasigroch,J.M., Gilis,D. and Rooman,M. (2011) BMCBioinfor-
matics., 12, 151.
Dellus-Gur,E., Toth-Petroczy,A., Elias,M. and Tawﬁk,D.S. (2013) J. Mol. Biol.,
425, 2609–2621.
Gaskell,A., Crennell,S. and Taylor,G. (1995) Structure, 3, 1197–1205.
Indurugalla,D., Watson,J.N. and Bennet,A.J. (2006) Org. Biomol. Chem., 4,
4453–4459.
Jarmer,H., Berka,R., Knudsen,S. and Saxild,H.H. (2002) FEMS Microbiol.
Lett., 206, 197–200.
Jers,C., Michalak,M., Larsen,D.M., Kepp,K.P., Li,H., Guo,Y., Kirpekar,F.,
Meyer,A.S. and Mikkelsen,J.D. (2014) PLoS One, 9, e83902.
Kepp,K.P. (2014) J. Phys. Chem. B., 118, 1799–1812.
Kepp,K.P. and Dasmeh,P. (2014) PLoS ONE, 9, e90504.
Khersonsky,O. and Tawﬁk,D.S. (2010) Annu. Rev. Biochem., 79, 471–505.
Khersonsky,O., Roodveldt,C. and Tawﬁk,D.S. (2006)Curr. Opin. Chem. Biol.,
10, 498–508.
Lee,C.C. (2010) Biofuels., 1, 575–588.
Martin-Verstraete,I., Débarbouillé,M., Klier,A. and Rapoport,G. (1990)
J. Mol. Biol., 214, 657–671.
Mountney,A., Zahner,M.R., Lorenzini,I., Oudega,M., Schramm,L.P. and
Schnaar,R.L. (2010) PNAS, 107, 11561–11566.
Nagatani,R.A., Gonzalez,A., Shoichet,B.K., Brinen,L.S. and Babbitt,P.C.
(2007) Biochemistry, 46, 6688–6695.
Øbro,J., Sørensen,I., Derkx,P., Madsen,C.T., Drews,M., Willer,M., Mikkelsen,
J.D. and Willats,W.G.T. (2009) Proteomics, 9, 1861–1868.
Paris,G., Ratier,L., Amaya,M.F., Nguyen,T., Alzari,P.M. and Frasch,A.C.
(2005) J. Mol. Biol., 345, 923–934.
Penninga,D., van der Veen,B.A., Knegtel,R.M., van Hijum,S.A., Rozeboom,H.
J., Kalk,K.H., Dijkstra,B.W. and Dijkhuizen,L. (1996) J. Biol. Chem., 271,
32777–32784.
Pierdominici-Sottile,G., Palma,J. and Roitberg,A.E. (2014) Proteins, 82, 424–435.
Saito,T. and Itoh,T. (1992) J. Diary Sci., 75, 1768–1774.
Sakurada,K., Ohta,T. and Hasegawa,M. (1992) J. Bacteriol., 174, 6896–6903.
Schmidt,D., Sauerbrei,B. and Thiem,J. (2000) J. Org. Chem., 65, 8518–8526.
Silva,I.R., Larsen,D.M., Jers,C., Derkx,P., Meyer,A.S. and Mikkelsen,J.D.
(2013) Appl. Microbiol. Biotechnol., 97, 9727–9735.
Studer,R.A., Christin,P.A., Williams,M.A. and Orengo,C.A. (2014) Proc. Natl
Acad. Sci. USA, 111, 2223–2228.
Tokuriki,N. and Tawﬁk,D.S. (2009) Science, 324, 203–207.
Tokuriki,N., Stricher,F., Serrano,L. and Tawﬁk,D.S. (2008) PLoS Comput.
Biol., 4, e1000002.
Tokuriki,N., Jackson,C.J., Afriat-Jurnou,L., Wyganowski,K.T., Tang,R. and
Tawﬁk,D.S. (2012) Nat. Commun., 3, 1257.
Tracewell,C.A. and Arnold,F.H. (2009) Curr. Opin. Chem. Biol., 13, 3–9.
Watson,J.N., Dookhun,V., Borgford,T.J. and Bennet,A.J. (2003) Biochemistry,
42, 12682–12690.
Watts,A.G., Damager,I., Amaya,M.L., Buschiazzo,A., Alzari,P., Frasch,A.C.
and Withers,S.G. (2003) J. Am. Chem. Soc., 125, 7532–7533.
Worth,C.L., Preissner,R. and Blundell,T.L. (2011) Nucleic Acids Res., 39,
W215–W222.
Wu,S.C., Yeung,J.C., Duan,Y., Ye,R., Szarka,S.J., Habibi,H.R. and Wong,S.L.
(2002) Appl. Environ. Microbiol., 68, 3261–3269.
Yang,L.J.S., Lorenzini,I., Vajn,K., Mountney,A., Schramm,L.P. and Schnaar,R.
L. (2006) PNAS, 103, 11057–11062.
Zhang,X. and Zhang,Y.P. (2011) Microb. Biotechnol., 4, 98–105.
44 C.Jers et al.
 at D
TU
 Library on February 4, 2015
http://peds.oxfordjournals.org/
D
ow
nloaded from
 
